Menopause

被引:180
作者
Davis, Susan R. [1 ]
Lambrinoudaki, Irene [2 ,3 ]
Lumsden, Maryann [4 ]
Mishra, Gita D. [5 ]
Pal, Lubna [6 ]
Rees, Margaret [7 ]
Santoro, Nanette [8 ]
Simoncini, Tommaso [9 ]
机构
[1] Monash Univ, Sch Publ Hlth & Prevent Med, 99 Commercial Rd, Melbourne, Vic 3004, Australia
[2] Univ Athens, Med Sch, Athens, Greece
[3] Aretaieio Univ Hosp, Athens, Greece
[4] Glasgow Royal Infirm, Reprod & Maternal Med, Glasgow, Lanark, Scotland
[5] Univ Queensland, Fac Med & Biomed Sci, Sch Populat Hlth, Brisbane, Qld 4072, Australia
[6] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA
[7] John Radcliffe Hosp, Womens Ctr, Oxford, England
[8] Univ Colorado, Sch Med, Aurora, CO USA
[9] Univ Pisa, Pisa, Italy
来源
NATURE REVIEWS DISEASE PRIMERS | 2015年 / 1卷
关键词
QUALITY-OF-LIFE; ANTI-MULLERIAN HORMONE; VULVO-VAGINAL ATROPHY; ESTROGEN PLUS PROGESTIN; CORONARY-HEART-DISEASE; MIDDLE-AGED WOMEN; BODY-MASS INDEX; POSTMENOPAUSAL WOMEN; VASOMOTOR SYMPTOMS; NATURAL MENOPAUSE;
D O I
10.1038/nrdp.2015.4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Menopause is an inevitable component of ageing and encompasses the loss of ovarian reproductive function, either occurring spontaneously or secondary to other conditions. It is not yet possible to accurately predict the onset of menopause, especially early menopause, to give women improved control of their fertility. The decline in ovarian oestrogen production at menopause can cause physical symptoms that may be debilitating, including hot flushes and night sweats, urogenital atrophy, sexual dysfunction, mood changes, bone loss, and metabolic changes that predispose to cardiovascular disease and diabetes. The individual experience of the menopause transition varies widely. Important influential factors include the age at which menopause occurs, personal health and wellbeing, and each woman's environment and culture. Management options range from lifestyle assessment and intervention through to hormonal and non-hormonal pharmacotherapy, each of which has specific benefits and risks. Decisions about therapy for perimenopausal and postmenopausal women depend on symptomatology, health status, immediate and long-term health risks, personal life expectations, and the availability and cost of therapies. More effective and safe therapies for the management of menopausal symptoms need to be developed, particularly for women who have absolute contraindications to hormone therapy. For an illustrated summary of this Primer, visit: http://go.nature.com/BjvJVX
引用
收藏
页数:19
相关论文
共 215 条
  • [51] Cardiovascular and cancer safety of testosterone in women
    Davis, Susan R.
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (03) : 198 - 203
  • [52] Androgen levels in adult females: Changes with age, menopause, and oophorectomy
    Davison, SL
    Bell, R
    Donath, S
    Montalto, JG
    Davis, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) : 3847 - 3853
  • [53] Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health
    de Villiers, T. J.
    Pines, A.
    Panay, N.
    Gambacciani, M.
    Archer, D. F.
    Baber, R. J.
    Davis, S. R.
    Gompel, A. A.
    Henderson, V. W.
    Langer, R.
    Lobo, R. A.
    Plu-Bureau, G.
    Sturdee, D. W.
    [J]. CLIMACTERIC, 2013, 16 (03) : 316 - 337
  • [54] Global Consensus Statement on menopausal hormone therapy
    de Villiers, T. J.
    Gass, M. L. S.
    Haines, C. J.
    Hall, J. E.
    Lobo, R. A.
    Pierroz, D. D.
    Rees, M.
    [J]. MATURITAS, 2013, 74 (04) : 391 - 392
  • [55] Primary ovarian insufficiency
    De Vos, Michel
    Devroey, Paul
    Fauser, Bart C. J. M.
    [J]. LANCET, 2010, 376 (9744) : 911 - 921
  • [56] The physiology and clinical utility of anti-Mllerian hormone in women
    Dewailly, Didier
    Andersen, Claus Yding
    Balen, Adam
    Broekmans, Frank
    Dilaver, Nafi
    Fanchin, Renato
    Griesinger, Georg
    Kelsey, Tom W.
    La Marca, Antonio
    Lambalk, Cornelius
    Mason, Helen
    Nelson, Scott M.
    Visser, Jenny A.
    Wallace, W. Hamish
    Anderson, Richard A.
    [J]. HUMAN REPRODUCTION UPDATE, 2014, 20 (03) : 370 - 385
  • [57] Profile of menopausal women in west Anatolian rural region sample
    Discigil, Guzel
    Gemalmaz, Ayfer
    Tekin, Nil
    Basak, Okay
    [J]. MATURITAS, 2006, 55 (03) : 247 - 254
  • [58] Do KA, 1998, HUM BIOL, V70, P1073
  • [59] The role of the brain in female reproductive aging
    Downs, Jodi L.
    Wise, Phyllis M.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 299 (01) : 32 - 38
  • [60] Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies
    Dratva, Julia
    Real, Francisco Gomez
    Schindler, Christian
    Ackermann-Liebrich, Ursula
    Gerbase, Margaret W.
    Probst-Hensch, Nicole M.
    Svanes, Cecilie
    Omenaas, Ernst Raidar
    Neukirch, Francoise
    Wjst, Matthias
    Morabia, Alfredo
    Jarvis, Deborah
    Leynaert, Benedicte
    Zemp, Elisabeth
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (02): : 385 - 394